Bone Therapeutics Successfully Raises EUR 3.3 Million in Private Placement Read more about Bone Therapeutics Successfully Raises EUR 3.3 Million in Private Placement
Bone Therapeutics announces closing of private placement Read more about Bone Therapeutics announces closing of private placement
Bone Therapeutics: Information on the total number of voting rights and shares Read more about Bone Therapeutics: Information on the total number of voting rights and shares
Transparency notification received from Nyenburgh Holding NV Read more about Transparency notification received from Nyenburgh Holding NV
Bone Therapeutics: Transparency notification received from S.R.I.W. SA and Sofipôle SA Read more about Bone Therapeutics: Transparency notification received from S.R.I.W. SA and Sofipôle SA
Bone Therapeutics provides fourth quarter 2021 business update and 2022 outlook Read more about Bone Therapeutics provides fourth quarter 2021 business update and 2022 outlook
Transparency notification received from Nyenburgh Holding NV Read more about Transparency notification received from Nyenburgh Holding NV
Bone Therapeutics to strategically focus on lead cell therapy product ALLOB Read more about Bone Therapeutics to strategically focus on lead cell therapy product ALLOB
Bone Therapeutics Secures EUR 5 Million Financing Read more about Bone Therapeutics Secures EUR 5 Million Financing
Bone Therapeutics announces 2021 full year results Read more about Bone Therapeutics announces 2021 full year results